Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer

Carcinogenesis

Volumn 31, Issue 3, 2010, Pages 350-358

  Tsang, Wing Pui ^a   Ng, Enders K O ^a   Ng, Simon S M ^b   Jin, Hongchuan ^a   Yu, Jun ^a   Sung, Joseph J Y ^a   Kwok, Tim Tak ^a  

^a State Key Laboratory in Oncology in South China   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 675; RETINOBLASTOMA PROTEIN; RNA H19; UNCLASSIFIED DRUG; MIRN675 MICRORNA, HUMAN; RNA; SMALL INTERFERING RNA; TUMOR PROTEIN; UNTRANSLATED RNA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TISSUE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION; 3' UNTRANSLATED REGION; ADENOCARCINOMA; BINDING SITE; CELL DIVISION; CELL TRANSFORMATION; COLORECTAL TUMOR; CYTOLOGY; DOWN REGULATION; DRUG SCREENING; FIBROBLAST; GENE EXPRESSION PROFILING; GENETICS; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL CULTURE;

3' UNTRANSLATED REGIONS; ADENOCARCINOMA; BINDING SITES; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DOWN-REGULATION; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; NEOPLASM PROTEINS; RETINOBLASTOMA PROTEIN; RNA INTERFERENCE; RNA, NEOPLASM; RNA, SMALL INTERFERING; RNA, UNTRANSLATED; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 77950881915     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp181     Document Type: Article

References (41)

1. Parkin, D.M. et al. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108.
2. Walsh, J.M. et al. (2003) Colorectal cancer screening: scientific review. JAMA, 289, 1288-1296.
3. Fearnhead, N.S. et al. (2002) Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br. Med. Bull., 64, 27-43.
4. Wolpin, B.M. et al. (2008) Systemic treatment of colorectal cancer. Gastroenterology, 134, 1296-1310.
5. Garzon, R. et al. (2006) MicroRNA expression and function in cancer. Trends Mol. Med., 12, 580-587.
6. Jovanovic, M. et al. (2006) miRNAs and apoptosis: RNAs to die for. Oncogene, 25, 6176-6187.
7. Zhang, B. et al. (2007) microRNAs as oncogenes and tumor suppressors. Dev. Biol., 302, 1-12.
8. Volinia, S. et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA, 103, 2257-2261.
9. Johnson, S.M. et al. (2005) RAS is regulated by the let-7 microRNA family. Cell, 120, 635-647.
10. Cimmino, A. et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA, 102, 13944-13949.
11. Michael, M.Z. et al. (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res., 1, 882-891.
12. Eis, P.S. et al. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl Acad. Sci. USA, 102, 3627-3632.
13. He, L. et al. (2005) A microRNA polycistron as a potential human oncogene. Nature, 435, 828-833.
14. Ayesh, S. et al. (2002) Possible physiological role of H19 RNA. Mol. Carcinog., 35, 63-74.
15. Matouk, I.J. et al. (2007) The H19 non-coding RNA is essential for human tumor growth. PLoS ONE, 2, e845.
16. Brannan, C.I. et al. (1990) The product of the H19 gene may function as an RNA. Mol. Cell. Biol., 10, 28-36.
17. Lustig, O. et al. (1994) Expression of the imprinted gene H19 in the human fetus. Mol. Reprod. Dev., 38, 239-246.
18. Hibi, K. et al. (1996) Loss of H19 imprinting in esophageal cancer. Cancer Res., 56, 480-482.
19. Cui, H. et al. (2002) Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res., 62, 6442-6446.
20. Ariel, I. et al. (1998) Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. Mol. Pathol., 51, 21-25.
21. Verkerk, A.J. et al. (1997) Unique expression patterns of H19 in human testicular cancers of different etiology. Oncogene, 14, 95-107.
22. Lustig-Yariv, O. et al. (1997) The expression of the imprinted genes H19 and IGF-2 in choriocarcinoma cell lines. Is H19 a tumor suppressor gene? Oncogene, 15, 169-177.
23. Tanos, V. et al. (1999) Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer. Eur. J. Obstet. Gynecol. Reprod. Biol., 85, 7-11.
24. Lottin, S. et al. (2002) Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis, 23, 1885-1895.
25. Elkin, M. et al. (1995) The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma. FEBS Lett., 374, 57-61.
26. Byun, H.M. et al. (2007) Examination of IGF2 and H19 loss of imprinting in bladder cancer. Cancer Res., 67, 10753-10758.
27. Ariel, I. et al. (2000) The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol. Pathol., 53, 320-323.
28. Rachmilewitz, J. et al. (1995) H19 expression and tumorigenicity of choriocarcinoma derived cell lines. Oncogene, 11, 863-870.
29. Cai, X. et al. (2007) The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA, 13, 313-316.
30. Perez, D.S. et al. (2008) Gene expression changes associated with altered growth and differentiation in benzo[a]pyrene or arsenic exposed normal human epidermal keratinocytes. J. Appl. Toxicol., 28, 491-508.
31. Kruger, J. et al. (2006) RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res., 34, W451-W454.
32. Semizarov, D. et al. (2004) siRNA-mediated gene silencing: a global genome view. Nucleic Acids Res., 32, 3836-3845.
33. Souglakos, J. (2007) Genetic alterations in sporadic and hereditary colorectal cancer: implementations for screening and follow-up. Dig. Dis., 25, 9-19.
34. Bandres, E. et al. (2006) Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer., 5, 29.
35. Khidr, L. et al. (2006) RB, the conductor that orchestrates life, death and differentiation. Oncogene, 25, 5210-5219.
36. Scambia, G. et al. (2006) RB family members as predictive and prognostic factors in human cancer. Oncogene, 25, 5302-5308.
37. DeGregori, J. (2004) The rb network. J. Cell Sci., 117, 3411-3413.
38. Bosco, E.E. et al. (2007) RB in breast cancer: at the crossroads of tumorigenesis and treatment. Cell Cycle, 6, 667-671.
39. Berteaux, N. et al. (2005) H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J. Biol. Chem., 280, 29625-29636.
40. Tsang, W.P. et al. (2007) Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells. Oncogene, 26, 4877-4881.
41. Wightman, B. et al. (1993) Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell, 75, 855-862.